Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Short-term Investments (2024 - 2025)

Plus Therapeutics (PSTV) has disclosed Short-term Investments for 2 consecutive years, with $3.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Short-term Investments fell 7.1% to $3.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.3 million, a 7.1% decrease, with the full-year FY2024 number at $3.5 million, changed N/A from a year prior.
  • Short-term Investments was $3.3 million for Q3 2025 at Plus Therapeutics, down from $4.6 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.6 million in Q2 2025 to a low of $323000.0 in Q1 2024.